期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Nanostructured boron agents for boron neutron capture therapy:a review of recent patents 被引量:1
1
作者 Xiyin Zhang Yusheng Lin +1 位作者 narayan shosmane Yinghuai Zhu 《Medical Review》 2023年第5期425-443,共19页
Boron neutron capture therapy(BNCT)is a potential radiation therapy modality for cancer,and tumortargeted stable boron-10(10B)delivery agents are an important component of BNCT.Currently,two low-molecular-weight boron... Boron neutron capture therapy(BNCT)is a potential radiation therapy modality for cancer,and tumortargeted stable boron-10(10B)delivery agents are an important component of BNCT.Currently,two low-molecular-weight boron-containing compounds,sodium mercaptoundecahydrocloso-dodecaborate(BSH)and boronophenylalanine(BPA),are mainly used in BNCT.Although both have suboptimal tumor selectivity,they have shown some therapeutic benefit in patients with high-grade glioma and several other tumors.To improve the efficacy of BNCT,great efforts have been devoted for the development of new boron delivery agents with better uptake and favorable pharmacokinetic profiles.This article reviews the application and research progress of boron nanomaterials as boron carriers in boron neutron capture therapy and hopes to stimulate people’s interest in nanomaterial-based delivery agents by summarizing various kinds of boron nanomaterial patents disclosed in the past decade. 展开更多
关键词 boron agent boron neutron capture therapy DENDRIMER drug delivery NANOMATERIAL
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部